CervoMed (CRVO) Metrics: History & Chart

CervoMed Inc.(CRVO)

Biotechnology · Boston, MA

$3.23-0.08 (-2.42%)

Delayed quote: Oct 6, 2026, 9:35 AM EDT

About CervoMed Inc.

CervoMed Inc., a clinical-stage biotechnology company, engages in the development and commercialization of treatments for age-related neurologic disorders. The company is developing neflamapimod, an orally administered small molecule drug that crosses the blood–brain barrier and inhibits the enzyme p38a. Neflamapimod has the potential to reverse synaptic dysfunction, improve neuron health, and slow or prevent disease progression. Neflamapimod is currently in clinical development for the treatment of dementia with Lewy bodies, non-fluent variant primary progressive aphasia, amyotrophic lateral sclerosis, and amyotrophic lateral sclerosis. CervoMed Inc. was founded in 2010 and is headquartered in Boston, Massachusetts.

Boston, MA

15 employees

www.cervomed.com

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: John J. Alam

View full financials

Third-Party DCF Estimate (FMP)	$0.80
Price Gap vs Third-Party Estimate	-75.72%

7D Total Return	+25.00%
30D Total Return	+36.36%
YTD Total Return	-57.14%
1Y Total Return	-61.54%
3Y Total Return	-37.50%
5Y Total Return	-91.02%
10Y Total Return	-99.96%
15Y Total Return	-100.00%
20Y Total Return	N/A

2026	-57.14%
2025	+250.00%
2024	-70.59%
2023	0.00%
2022	-66.99%
2021	-61.42%
2020

CAGR TTM	-61.36%
CAGR 3Y	-14.50%
CAGR 5Y	-38.25%
CAGR 10Y	-53.96%
CAGR 15Y	-62.34%
CAGR 20Y	N/A

PE Ratio	769.44
PE Ratio Avg TTM	876.90
PE Ratio Avg 3Y	876.90
Current VS TTM Avg	-12.25%
Current VS 3Y Avg	-12.25%
Current VS 5Y Avg	-12.25%

All Metrics

CRVO Valuation Metrics

CRVO Stock Price Metrics

CRVO Dividend Metrics

CRVO Growth Rate Metrics

CRVO Discounted Cash Flow Metrics

CRVO Returns By Period

CRVO Yearly Returns

CRVO Average Annual Returns By Period (CAGR)

CRVO Revenue Metrics

CRVO PE Ratio Metrics

CRVO PS Ratio Metrics

CRVO PB Ratio Metrics

CRVO Price to Free Cash Flow Ratio Metrics

CRVO Debt to Equity Ratio Metrics

CRVO PEG Ratio Metrics

CRVO FCF Yield

CRVO Earnings Yield

CRVO EBITDA Yield

CRVO OCF Yield

CRVO EV/EBIT Ratio Metrics

CRVO EV/EBITDA Ratio Metrics

CRVO EV/Assets Ratio Metrics

CRVO EV/Sales Ratio Metrics

CRVO Current Ratio Metrics

CRVO Quick Ratio Metrics

CRVO ROIC Metrics

CRVO Return on Assets Metrics

CRVO Return on Equity Metrics

CRVO Net Profit Margin Metrics

CRVO Gross Profit Margin Metrics

CRVO Tax Rate Metrics

PS Ratio	105.12
PS Ratio Avg TTM	123.78
PS Ratio Avg 3Y	123.78
Current VS TTM Avg	-15.07%
Current VS 3Y Avg	-15.07%
Current VS 5Y Avg	-15.07%

PB Ratio	1.48
PB Ratio Avg TTM	2.16
PB Ratio Avg 3Y	2.26
Current VS TTM Avg	-31.45%
Current VS 3Y Avg	-34.37%
Current VS 5Y Avg	-7.53%

PFCF Ratio	N/A
PFCF Ratio Avg TTM	N/A
PFCF Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Debt/Equity Ratio	0.00
Debt/Equity Ratio Avg TTM	0.00
Debt/Equity Ratio Avg 3Y	0.00
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

PEG Ratio	N/A
PEG Ratio Avg TTM	N/A
PEG Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

FCF Yield	N/A
FCF Yield Avg TTM	N/A
FCF Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Earnings Yield	0.13%
Earnings Yield Avg TTM	0.12%
Earnings Yield Avg 3Y	0.12%
Current VS TTM Avg	+11.43%
Current VS 3Y Avg	+11.43%
Current VS 5Y Avg	+11.43%

EBITDA Yield	N/A
EBITDA Yield Avg TTM	N/A
EBITDA Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

OCF Yield	N/A
OCF Yield Avg TTM	N/A
OCF Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Ev/Ebit Ratio	0.01
Ev/Ebit Ratio Avg TTM	0.36
Ev/Ebit Ratio Avg 3Y	0.66
Current VS TTM Avg	-97.25%
Current VS 3Y Avg	-98.48%
Current VS 5Y Avg	-98.48%

Ev/Ebitda Ratio	0.01
Ev/Ebitda Ratio Avg TTM	0.36
Ev/Ebitda Ratio Avg 3Y	0.66
Current VS TTM Avg	-97.24%
Current VS 3Y Avg	-98.48%
Current VS 5Y Avg	-98.48%

Ev/Assets Ratio	0.44
Ev/Assets Ratio Avg TTM	1.33
Ev/Assets Ratio Avg 3Y	1.50
Current VS TTM Avg	-66.90%
Current VS 3Y Avg	-70.67%
Current VS 5Y Avg	-69.14%

Ev/Sales Ratio	35.49
Ev/Sales Ratio Avg TTM	88.95
Ev/Sales Ratio Avg 3Y	88.95
Current VS TTM Avg	-60.10%
Current VS 3Y Avg	-60.10%
Current VS 5Y Avg	-60.10%

Current Ratio	8.57
Current Ratio Avg TTM	8.81
Current Ratio Avg 3Y	8.04
Current VS TTM Avg	-2.74%
Current VS 3Y Avg	+6.67%
Current VS 5Y Avg	-13.94%

Quick Ratio	8.57
Quick Ratio Avg TTM	8.81
Quick Ratio Avg 3Y	8.04
Current VS TTM Avg	-2.74%
Current VS 3Y Avg	+6.67%
Current VS 5Y Avg	-13.94%

ROIC	(135.73%)
ROIC Avg 3Y	(87.18%)
ROIC Avg 5Y	(79.67%)
Current VS 3Y Avg	-55.69%
Current VS 5Y Avg	-70.38%
Current VS 10Y Avg	-114.70%

ROA	(116.76%)
ROA Avg TTM	(30.84%)
ROA Avg 3Y	(18.91%)
Current VS TTM Avg	-278.55%
Current VS 3Y Avg	-517.29%
Current VS 5Y Avg	-628.83%

ROE	(132.18%)
ROE Avg TTM	(145.82%)
ROE Avg 3Y	(64.53%)
Current VS TTM Avg	+9.35%
Current VS 3Y Avg	-104.84%
Current VS 5Y Avg	-120.82%

Net Profit Margin	(9408.76%)
Net Profit Margin Avg TTM	(479.07%)
Net Profit Margin Avg 3Y	0.00%
Current VS TTM Avg	-1863.97%
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Gross Profit Margin	0.00%
Gross Pft Margin Avg TTM	20.00%
Gross Pft Margin Avg 3Y	0.00%
Current VS TTM Avg	-100.00%
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Tax Rate	0.00%
Tax Rate Avg 3Y	N/A
Tax Rate Avg 5Y	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A
Current VS 10Y Avg	+100.00%